左西孟旦注射液和三磷酸腺苷受体拮抗剂西地兰治疗重度心肌病心力衰竭被引量：7

在线阅读下载PDF

导出

摘要目的探讨左西孟旦注射液和三磷酸腺苷(ATP)受体拮抗剂西地兰治疗不佳的重度心肌病心力衰竭患者临床效果。方法选取2010年10月—2013年10月常规治疗不佳的重度心肌病心力衰竭68例,采用数字随机法分为两组,34例采用三磷酸腺苷受体拮抗剂西地兰治疗为对照组,34例患者采用左西孟旦注射液治疗为观察组。比较两组治疗前后心功能改善、相关指标、治疗效果、不良事件情况。结果治疗后,两组患者心功能分级情况均明显改善,心功能分级评分、B型脑钠肽均明显降低,左室射血分数、6min步行距离均显著增加(P<0.05)。结论左西孟旦注射液和三磷酸腺苷受体拮抗剂西地兰均是治疗重度心肌病心力衰竭的有效药物。

作者郑微微

机构地区辽宁省本溪市本钢总医院

出处《中西医结合心脑血管病杂志》 2015年第5期635-637,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease

关键词重度心肌病心力衰竭左西孟旦三磷酸腺苷受体拮抗剂西地兰

分类号 R542.2 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献15

1Milton P,Peter C,Uri E,et al.Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy:Results of the PRAISE-2 Study(Prospective Randomized Amlodipine Survival Evaluation 2)[J].JACC:Heart Failure,2013,1(4):308-314.
2Sanaz P,Peter L,Ana VA,et al.Where genome meets phe-nome:Rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure[J],J Am Coll Cardiology,2012,60(4):283-289.
3Paul FK,Paolo R,Steven L,et al.Current applications and future needs for biomarkers in pediatric cardiomyopathy and heart failure:Summary from the second international conference on pediatric cardiomyopathy[J].Progress Pediatric Cardiology,2011,32(1):11-14.
4韩静,王建明.左西孟旦治疗重度扩张型心肌病心力衰竭的临床观察[J].中国药物与临床,2014,14(1):90-92. 被引量：9
5杨新华,杜松.普伐他汀对扩张性心肌病心力衰竭患者心功能的影响[J].中华实用诊断与治疗杂志,2012,26(9):881-882. 被引量：13
6董赛晓,邓志鹏,白丽秀,范红霞,陈俊霞.左卡尼汀注射液联合参麦注射液治疗缺血性心肌病心力衰竭疗效观察[J].中国中医急症,2012,21(5):817-818. 被引量：23
7Carlos AV,Patricia MCtMirta D,et al.Cardiomyocyte hypertrophy,oncosis,and autophagic vacuolization predict mortality in idiopathic dilated cardiomyopathy with advanced heart failure[J].J Am Coll Cardiology,2011,57(14):1523-1531.
8Seth AH,Linda JA,Clifford C,et al.Abdominal complaints as a common first presentation of heart failure in adolescents with dilated cardiomyopathy[J].Am J Emergency Medicine,2013,31(4):684-686.
9Gius印pe S,Giuseppe N,Felice P,et al.One-year results after implantation of the corcap for dilated cardiomyopathy and heart failure[J].An Thoracic Surgery,2011,91(5):1356-1362.
10母靖岚.西地兰治疗心力衰竭的临床观察和护理配合[J].中国社区医师（医学专业）,2011,13(25):255-256. 被引量：3

二级参考文献70

1金先桥,段生福,牛汝楫,张珍祥,徐永健.参麦注射液及其配伍对慢性缺氧鼠血气及血流动力学的影响[J].中国中西医结合杂志,1995,15(3):162-164. 被引量：144
2章耀,林斌,季晓君,林苗,王凯华,黄旭梅,贾珠银,杨丽翠,王军,曾向村.静脉注射常用剂量倍他乐克对冠心病左心室脑利钠肽水平的影响[J].心血管康复医学杂志,2006,15(2):154-155. 被引量：2
3毛静远,张伯礼,王贤良.参麦注射液治疗心力衰竭机制研究进展[J].中成药,2006,28(12):1801-1803. 被引量：47
4禹蒙军.美托洛尔治疗扩张型心肌病心力衰竭的疗效观察[J].医学临床研究,2007,24(2):328-330. 被引量：4
5Task Force Members, Jose Lopez - Sendon, Chairperson, Karl, et al. Expert consensus doc- ument on β - adrenergic receptor blockers [J]. The Task Force Beta- Blockers of the Europea Ⅱ Society of Cardiology. European Heart Journal,2004,25 : 1341 - 1362.
6Calvani M, Reda E, Arriggoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohyderate metabolism,under normal and pathological conditions [ J ]. Basic Res Cardiol, 2000,95 (20) : 75-83.
7Evans AM, Fornasini G. Pharmacokinetics of L-carnitine [J ]. Chin Pharmacokinet, 2003,42 ( 11 ) : 941-967.
8Schaper J, Elsasser A, Kostin S. The role of cell death in heart failure[J]. Circ Res, 1999,85(6) :867-869.
9Baker H,DeAngelis B,Orlando J,et al. Cardica carnitine leakage is promoted by cardiomyopathy [ J ]. Nutrition, 2005,21 (3) : 348-350.
10张子彬,郑宗锷.充血性心力衰竭[M].北京:科学技术文献出版社,1999:259.